Related Experiment Video
Updated: Jun 5, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children
Brady S Moffett1, Stuart L Goldstein
1Texas Children's Hospital, Department of Pharmacy, 6621 Fannin Street, MC 2-2510, Houston, TX 77030, USA. bsmoffet@texaschildrens.org
Insights
Hospitalized children exposed to multiple nephrotoxic medications face a higher risk of acute kidney injury (AKI). This increases hospital costs and patient morbidity, highlighting the need for careful medication management in pediatric care.
Area of Science:
- Pediatric Nephrology
- Clinical Pharmacology
- Hospital Medicine
Background:
- Acute kidney injury (AKI) in children leads to significant morbidity and mortality.
- Nephrotoxic medication exposure is a primary contributor to AKI in pediatric populations.
- Limited data exist on specific nephrotoxic medication risks in children.
Purpose of the Study:
- To investigate the association between nephrotoxic medication exposure and AKI risk.
- To quantify the risk of AKI in hospitalized children without pre-existing renal conditions.
- To evaluate the impact of nephrotoxic medication exposure on pediatric AKI development.
Main Methods:
- Retrospective case-control study design.
- Inclusion of pediatric patients (1 day to 18 years) without prior renal insufficiency.
- AKI diagnosis based on pediatric-modified Risk, Injury, Failure, Loss, End-Stage (pRIFLE) criteria; controls matched for age, gender, and disease state.
Main Results:
- 33.8% of hospitalized children developed AKI.
- Patients with AKI had longer hospital stays and higher costs.
- Exposure to more nephrotoxic medications, and for longer durations, significantly increased AKI risk.
Conclusions:
- Exposure to three or more nephrotoxic medications elevates pediatric AKI risk.
- Increased AKI risk is associated with greater hospital costs and patient morbidity.
- This study underscores the importance of monitoring nephrotoxic medication exposure in hospitalized children.
Background And Objectives:
Acute kidney injury (AKI) in hospitalized children results in increased patient morbidity and mortality. Nephrotoxic-medication exposure is a common cause of AKI. Currently, no data exist to quantify the risks of developing AKI for various nephrotoxic medications in children. The primary aim of the current study is to assess for a potential association between nephrotoxic medications and the risk of developing AKI in hospitalized noncritically ill children with no pre-existing renal insufficiency.
Design, Setting, Participants, & Measurements:
We performed a retrospective case-control study in pediatric hospitalized noncritically ill patients aged 1 day to 18 years. The cases were patients who developed AKI, as defined by the pediatric modified RIFLE (pRIFLE) criteria; patients without AKI served as controls and were matched by age category, gender, and disease state.
Results:
561/1660 (33.8%) patients identified for inclusion had AKI (441 category "R," 117 category "I," three category "F"); 357 cases were matched with 357 controls. Patients with AKI had longer length of hospital stay and increased hospital costs. Patients with AKI had exposure to more nephrotoxic medications for a longer period of time compared with controls. Odds of exposure for at least one nephrotoxic medication was significant for development of AKI. Exposure to more nephrotoxic medications was associated with an increased risk of AKI.
Conclusions:
Increasing exposure to three or more nephrotoxic medications places pediatric patients at greater risk of acute kidney injury with resultant increased hospital costs and patient morbidity.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Pharmacokinetics in Pediatric Patients: Drug Excretion

